Ferrer I - Search Results

1

Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J. Ferrer I, et al. Curr Alzheimer Res. 2005 Jan;2(1):3-18. doi: 10.2174/1567205052772713. Curr Alzheimer Res. 2005. PMID: 15977985 Review.

2

Distribution of fibroblast growth factor receptor-1 (FGFR-1) and FGFR-3 in the hippocampus of patients with Alzheimer's disease.

Ferrer I, Martí E. Ferrer I, et al. Neurosci Lett. 1998 Jan 16;240(3):139-42. doi: 10.1016/s0304-3940(97)00948-8. Neurosci Lett. 1998. PMID: 9502223

3

Bcl-2 and Bax protein expression in Alzheimer's disease.

Tortosa A, López E, Ferrer I. Tortosa A, et al. Among authors: ferrer i. Acta Neuropathol. 1998 Apr;95(4):407-12. doi: 10.1007/s004010050817. Acta Neuropathol. 1998. PMID: 9560019

4

BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies.

Ferrer I, Marín C, Rey MJ, Ribalta T, Goutan E, Blanco R, Tolosa E, Martí E. Ferrer I, et al. J Neuropathol Exp Neurol. 1999 Jul;58(7):729-39. doi: 10.1097/00005072-199907000-00007. J Neuropathol Exp Neurol. 1999. PMID: 10411343

5

N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease.

Ferrer I, Blanco R. Ferrer I, et al. Brain Res Mol Brain Res. 2000 May 5;77(2):270-6. doi: 10.1016/s0169-328x(00)00062-0. Brain Res Mol Brain Res. 2000. PMID: 10837922

6

Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.

Ferrer I, Puig B, Blanco R, Martí E. Ferrer I, et al. Neuroscience. 2000;97(4):715-26. doi: 10.1016/s0306-4522(00)00045-2. Neuroscience. 2000. PMID: 10842016

7

Methylazoximethanol acetate-induced cell death in the granule cell layer of the developing mouse cerebellum is associated with caspase-3 activation, but does not depend on the tissue-type plasminogen activator.

Ferrer I, Puig B, Goutan E, Gombau L, Muñoz-Cánoves P. Ferrer I, et al. Neurosci Lett. 2001 Feb 16;299(1-2):77-80. doi: 10.1016/s0304-3940(01)01494-x. Neurosci Lett. 2001. PMID: 11166942

8

Prion protein expression in senile plaques in Alzheimer's disease.

Ferrer I, Blanco R, Carmona M, Puig B, Ribera R, Rey MJ, Ribalta T. Ferrer I, et al. Acta Neuropathol. 2001 Jan;101(1):49-56. doi: 10.1007/s004010000271. Acta Neuropathol. 2001. PMID: 11194941

9

Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, Puig B, Rey MJ, Cardozo A, Viñals F, Ribalta T. Ferrer I, et al. Brain Pathol. 2001 Apr;11(2):144-58. doi: 10.1111/j.1750-3639.2001.tb00387.x. Brain Pathol. 2001. PMID: 11303790 Free PMC article.

10

Cleaved caspase-3, caspase-7 and poly (ADP-ribose) polymerase are complementarily but differentially expressed in human medulloblastomas.

Puig B, Tortosa A, Ferrer I. Puig B, et al. Among authors: ferrer i. Neurosci Lett. 2001 Jun 22;306(1-2):85-8. doi: 10.1016/s0304-3940(01)01873-0. Neurosci Lett. 2001. PMID: 11403964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,367 results

Search Page

Filters